Minneapolis Heart Institute Foundation

Valve Science Center

A world-class research and education center for valvular heart disease, a life-threatening and debilitating condition when left untreated.

Join us in our mission to save the lives of patients with valvular heart disease!

Patients
For more information about valvular heart disease and current research studies, view the Valve Science Center patients page.
Physicians
Learn about landmark achievements and publications and meet the team.
Donors
Support the mission and innovative work at the Valve Science Center and impact millions of lives.

Latest News

Sorajja in MedPage Today on Valve Center Definitions

Dr. Paul Sorajja, Roger L. and Lynn C. Headrick Family Chair for Valve Science Research at MHIF's Valve Science Center, was interviewed by MedPage Today recently regarding...

MHIF Valve Science Center Publishes TMVR Data in JACC

Data from Largest Clinical Experience with Transcatheter Mitral Valve Replacement Published in Journal of the American College of CardiologyGlobal feasibility study enrolled symptomatic patients with primary or...

MHIF Well Represented at CRT2019

Several researchers from Minneapolis Heart Institute Foundation represented at CRT2019 in Washington D.C. the first weekend in March. Amongst the team, there was a total of 43...

Valve Science Center Research Published in JAMA Cardiology

MHIF Valve Science Center Researchers, Drs. Miho Fukui and Joao Cavalcante authored a recent paper published in JAMA Cardiology regarding TAVR outcomes in aortic stenosis patients. Read...

Valve Science Center Featured in Delta SkyMiles Ad

Leading into Valve Disease Awareness Day (February 22), Minneapolis Heart Institute Foundation's Valve Science Center was featured in the Delta SkyMiles ad. Dr. Paul Sorajja, Roger L....

See All News

Landmark Achievements
  • First transcatheter mitral valve replacement in the U.S. Read more.
  • First-in-human therapy of severe mitral annular calcification. Read more.
  • First-in-human therapy of tricuspid regurgitation with the TriClip. Read more.
  • First-in-human therapy with the MyoCor device for treatment of mitral regurgitation. Read more.
  • First-in-human therapy of hypertrophic cardiomyopathy with MitraClip. Read more.
Read about the team of physicians, scholars and staff at the Valve Science Center.
Meet the Team

Want to stay informed with Valve Science Center News? Join the mailing list!

3 + 6 =